The question facing supply chain leaders isn’t whether to adopt more technology, but how intentionally to invest in systems that will govern decision-making for the next decade.
Trade unpredictability exposes vulnerabilities in the pharmaceutical supply chain that must be addressed to build resilient systems ensuring patient access despite geopolitical challenges.
In an era where organizations move faster and margins for error shrink, the ability to execute and adapt under pressure isn’t just an operational skill. It’s a leadership one.
After years of reacting to disruption, leaders are shifting their focus away from reinvention, and back toward discipline and accountability in how work gets done.